Skip to main content
. 2015 May 21;14:108. doi: 10.1186/s12943-015-0371-8

Figure 2.

Figure 2

Kaplan-Meier-analysis for HOTAIR expression and cancer-specific survival. Kaplan-Meier-analysis revealed a significant advantage with regard to cancer-specific survival (p = 0.009) for patients with low HOTAIR expression (including 75% of patients with low or average HOTAIR expression levels) when compared with the 25% of patients with highest HOTAIR expression levels. Survival time is given in months.